-
1Academic Journal
المؤلفون: van Bruggen, F H, Zuidema, S U, Luijendijk, H J
المصدر: van Bruggen , F H , Zuidema , S U & Luijendijk , H J 2024 , ' Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials : a meta-epidemiological study ' , BMC Medical Research Methodology , vol. 24 , 137 . https://doi.org/10.1186/s12874-024-02260-z
مصطلحات موضوعية: Humans, Antibodies, Monoclonal, Humanized/therapeutic use, Monoclonal/therapeutic use, Cholesterol, LDL/blood, Male, Anticholesteremic Agents/therapeutic use, Randomized Controlled Trials as Topic, Female, Treatment Outcome, Middle Aged, Hypercholesterolemia/drug therapy, PCSK9 Inhibitors/therapeutic use, Aged, Proprotein Convertase 9
وصف الملف: application/pdf
-
2Academic Journal
المؤلفون: Reiner, Željko, Miličić, Davor, Rogić, Dunja, Manola, Šime, Ružić, Alen, Canecki-Vražić, Silvija, Kristić, Ivica, Bilić Zulle, Lidija, Đerek, Lovorka, Šerić, Vatroslav, Tandara, Leida
المصدر: Liječnički vjesnik ; Volume 146 ; Issue 1-2 ; ISSN 0024-3477 (Print) ; ISSN 1849-2177 (Online) ; https://hrcak.srce.hr/314685
مصطلحات موضوعية: KARDIOVASKULARNE BOLESTI – epidemiologija, etiologija, prevencija, ATEROSKLEROZA – epidemologija, SEKUNDARNA PREVENCIJA, LIPOPROTEIN(a)- genetika, u krvi, STENOZA AORTNIH ZALISTAKA – epidemiologija, KALCINOZA, LDL KOLESTEROL – u krvi, HIPERLIPIDEMIJE – farmakoterapija, PCSK9 INHIBITORI – terapijska uporaba, MALA INTERFERIRAJUĆA RNK – terapijska uporaba, STATINI – terapijska uporaba, ČIMBENICI RIZIKA, CARDIOVASCULAR DISEASES – epidemiology,etiology, prevention and control, ATHEROSCLEROSIS – epidemiology,etiology, SECONDARY PREVENTION, LIPOPROTEIN(a) – blood, genetics, AORTIC VALVE STENOSIS – epidemiology,etiology, CALCINOSIS, CHOLESTEROL, LDL – u krvi, HYPERLIPIDEMIAS – drug therapy, PCSK9 INHIBITORS – therapeutic use, RNA, SMALL INTERFERING – therapeutic use, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS – therapeutic use
وصف الملف: application/pdf
Relation: Sveučilište u Rijeci. Medicinski fakultet. Katedra za internu medicinu.; University of Rijeka. Faculty of Medicine. Department of Internal Medicine.; Sveučilište u Rijeci. Medicinski fakultet. Katedra za kliničko-laboratorijsku dijagnostiku.; University of Rijeka. Faculty of Medicine. Department of Clinical Laboratory Diagnostics.; https://www.unirepository.svkri.uniri.hr/islandora/object/medri:8483; https://urn.nsk.hr/urn:nbn:hr:184:542122; https://www.unirepository.svkri.uniri.hr/islandora/object/medri:8483/datastream/FILE0
-
3Academic Journal
المؤلفون: Khatib, Rani, Angus, Neil, Hansen, Tina B, Lambrinou, Ekaterini, Vellone, Ercole, Khan, Mutiba, Lee, Geraldine A
المصدر: Khatib , R , Angus , N , Hansen , T B , Lambrinou , E , Vellone , E , Khan , M & Lee , G A 2022 , ' Perceptions of injectable therapies with cardiovascular benefit : an ACNAP survey of healthcare professionals to explore facilitators and barriers ' , European Journal of Cardiovascular Nursing , vol. 21 , no. 5 , pp. 430-437 . https://doi.org/10.1093/eurjcn/zvab106
مصطلحات موضوعية: Cardiovascular System, Delivery of Health Care, Glucagon-Like Peptide-1 Receptor/antagonists & inhibitors, Health Personnel, Humans, PCSK9 Inhibitors/therapeutic use, Surveys and Questionnaires
-
4Academic Journal
المؤلفون: Koskinas, Konstantinos C, Gencer, Baris, Nanchen, David, Branca, Mattia, Carballo, David Andrés, Klingenberg, Roland, Blum, Manuel R, Carballo, Juan Sebastian, Muller, Olivier, Matter, Christian M, Lüscher, Thomas F, Rodondi, Nicolas, Heg, Dik, Wilhelm, Matthias, Räber, Lorenz, Mach, François, Windecker, Stephan
المصدر: ISSN: 2047-4873 ; European journal of preventive cardiology, vol. 28, no. 1 (2021) p. 59-65.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Lipids, PCSK9 inhibitors, Ezetimibe, Secondary prevention, Statins, Atherosclerosis, Cardiology, Cardiovascular Diseases, Europe, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use, PCSK9 Inhibitors / therapeutic use, Practice Guidelines as Topic, Proprotein Convertase 9, Prospective Studies, Societies, Medical, United States
Relation: info:eu-repo/semantics/altIdentifier/pmid/33755142; https://archive-ouverte.unige.ch/unige:164691; unige:164691
-
5Academic Journal
المؤلفون: Koskinas, K.C., Gencer, B., Nanchen, D., Branca, M., Carballo, D., Klingenberg, R., Blum, M.R., Carballo, S., Muller, O., Matter, C.M., Lüscher, T.F., Rodondi, N., Heg, D., Wilhelm, M., Räber, L., Mach, F., Windecker, S.
المصدر: European journal of preventive cardiology, vol. 28, no. 1, pp. 59-65
مصطلحات موضوعية: Atherosclerosis, Cardiology, Cardiovascular Diseases, Europe, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, PCSK9 Inhibitors/therapeutic use, Practice Guidelines as Topic, Proprotein Convertase 9, Prospective Studies, Societies, Medical, United States, Lipids, PCSK9 inhibitors, ezetimibe, secondary prevention, statins
وصف الملف: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/33755142; info:eu-repo/semantics/altIdentifier/eissn/2047-4881; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_93EA67EF9F1C2; https://serval.unil.ch/notice/serval:BIB_93EA67EF9F1C; https://serval.unil.ch/resource/serval:BIB_93EA67EF9F1C.P002/REF.pdf
-
6Electronic Resource
Additional Titles: Elevated lipoprotein (a) – an independent risk factor for cardiovascular disease – recommendations for measuring and treatment
المؤلفون: Reiner, Željko, Miličić, Davor, Rogić, Dunja, Manola, Šime, Ružić, Alen, Canecki-Vražić, Silvija, Kristić, Ivica, Bilić Zulle, Lidija, Đerek, Lovorka, Šerić, Vatroslav, Tandara, Leida
المصدر: Liječnički vjesnik; ISSN 0024-3477 (Print); ISSN 1849-2177 (Online); Volume 146; Issue 1-2
مصطلحات الفهرس: KARDIOVASKULARNE BOLESTI – epidemiologija, etiologija, prevencija; ATEROSKLEROZA – epidemologija, etiologija, prevencija; SEKUNDARNA PREVENCIJA; LIPOPROTEIN(a)- genetika, u krvi; STENOZA AORTNIH ZALISTAKA – epidemiologija, etiologija, prevencija; KALCINOZA; LDL KOLESTEROL – u krvi; HIPERLIPIDEMIJE – farmakoterapija; PCSK9 INHIBITORI – terapijska uporaba; MALA INTERFERIRAJUĆA RNK – terapijska uporaba; STATINI – terapijska uporaba; ČIMBENICI RIZIKA, CARDIOVASCULAR DISEASES – epidemiology,etiology, prevention and control; ATHEROSCLEROSIS – epidemiology,etiology, prevention and control; SECONDARY PREVENTION; LIPOPROTEIN(a) – blood, genetics; AORTIC VALVE STENOSIS – epidemiology,etiology, prevention and control; CALCINOSIS; CHOLESTEROL, LDL – u krvi; HYPERLIPIDEMIAS – drug therapy; PCSK9 INHIBITORS – therapeutic use; RNA, SMALL INTERFERING – therapeutic use; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS – therapeutic use; RISK FACTORS, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
URL:
https://hrcak.srce.hr/314685 https://hrcak.srce.hr/file/454714
info:eu-repo/semantics/altIdentifier/doi/10.26800/LV-146-1-2-7